Back to results
US 2023/0398069 A1Published application
Etoposide toniribate formulation
AssigneeCellAct Pharma GmbH
InventorsDavide GUGGI, Anna MONTES VÁZQUEZ, Javier MARTÍNEZ RUBIO, Rudy THOMA
Life of this patent
Estimating the term…
Abstract
A liquid pharmaceutical formulation comprising etoposide toniribate; a polysorbate; and ethanol. A method of preparing an infusion solution comprising diluting said liquid pharmaceutical formulation. Said composition or solution for use in treating cancer in a patient in need thereof.
Claims49
A liquid pharmaceutical formulation comprising:
- etoposide toniribate;
- a polysorbate;
- and
- ethanol.
1 more element
(canceled)
24-26. (canceled)
A liquid pharmaceutical formulation comprising:
- Etoposide toniribate;
- PEG;
- a polysorbate;
- Ethanol;
- Benzyl alcohol.
2 more elements
32-33. (canceled)
35-37. (canceled)
(canceled)
(canceled)
53-55. (canceled)
Dependencies are inferred from the claim text.